Search Results - "London, W. B."

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project by Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J

“…Background: In the INRG dataset, the hypothesis that any segmental chromosomal alteration might be of prognostic impact in neuroblastoma without MYCN…”
Get full text

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study by Wang, L L, Teshiba, R, Ikegaki, N, Tang, X X, Naranjo, A, London, W B, Hogarty, M D, Gastier-Foster, J M, Look, A T, Park, J R, Maris, J M, Cohn, S L, Seeger, R C, Asgharzadeh, S, Shimada, H

“…Background: MYCN amplification with subsequent MYCN protein overexpression is a powerful indicator of poor prognosis of neuroblastoma patients. Little is known…”
Get full text

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee by AMBROS, P. F, AMBROS, M, COHN, S. L, PEARSON, Adj, MARIS, J. M, BRODEUR, G. M, HABER, M, KHAN, J, NAKAGAWARA, A, SCHLEIERMACHER, G, SPELEMAN, F, SPITZ, R, LONDON, W. B

Get full text

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group by LONDON, W. B, CASTLEBERRY, R. P, COHN, S. L, MATTHAY, K. K, LOOK, A. T, SEEGER, R. C, SHIMADA, H, THORNER, P, BRODEUR, G, MARIS, J. M, REYNOLDS, C. P

“…In the Children's Oncology Group, risk group assignment for neuroblastoma is critical for therapeutic decisions, and patients are stratified by International…”
Get full text

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 by Seif, A E, Naranjo, A, Baker, D L, Bunin, N J, Kletzel, M, Kretschmar, C S, Maris, J M, McGrady, P W, von Allmen, D, Cohn, S L, London, W B, Park, J R, Diller, L R, Grupp, S A

“…Increasing treatment intensity has improved outcomes for children with neuroblastoma. We performed a pilot study in the Children’s Oncology Group to assess the…”
Get full text

Integrating Cell-Based and Clinical Genome-Wide Studies to Identify Genetic Variants Contributing to Treatment Failure in Neuroblastoma Patients by Pinto, N, Gamazon, E R, Antao, N, Myers, J, Stark, A L, Konkashbaev, A, Im, H K, Diskin, S J, London, W B, Ludeman, S M, Maris, J M, Cox, N J, Cohn, S L, Dolan, M E

“…High‐risk neuroblastoma is an aggressive malignancy, with high rates of treatment failure. We evaluated genetic variants associated with in vitro sensitivity…”
Get full text

CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression by Liu, Z, Yang, X, Li, Z, McMahon, C, Sizer, C, Barenboim-Stapleton, L, Bliskovsky, V, Mock, B, Ried, T, London, W B, Maris, J, Khan, J, Thiele, C J

Get full text

Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma by Rameh, V, Vajapeyam, S, Ziaei, A, Kao, P, London, W B, Baker, S J, Chiang, J, Lucas, J, Tinkle, C L, Wright, K D, Poussaint, T Y

“…Molecular profiling is a crucial feature in the "integrated diagnosis" of CNS tumors. We aimed to determine whether radiomics could distinguish molecular types…”
Get full text

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee by Ambros, P F, Ambros, I M, Brodeur, G M, Haber, M, Khan, J, Nakagawara, A, Schleiermacher, G, Speleman, F, Spitz, R, London, W B, Cohn, S L, Pearson, A D J, Maris, J M

“…Neuroblastoma serves as a paradigm for utilising tumour genomic data for determining patient prognosis and treatment allocation. However, before the…”
Get full text

CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression by Liu, Z, Yang, X, Li, Z, McMahon, C, Sizer, C, Barenboim-Stapleton, L, Bliskovsky, V, Mock, B, Ried, T, London, W B, Maris, J, Khan, J, Thiele, C J

“…Neuroblastoma (NB) is a common childhood malignant tumor of the neural crest-derived sympathetic nervous system. In NB the frequent loss of heterozygosity…”
Get full text

Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation by Song, J S, London, W B, Hawryluk, E B, Guo, D, Sridharan, M, Fisher, D E, Lehmann, L E, Duncan, C N, Huang, J T

“…There is a known increased risk of skin cancer in the adult population after hematopoietic stem cell transplantation (HSCT). However, late dermatologic effects…”
Get full text

Treatment and Outcome of 83 Children With Intraspinal Neuroblastoma: The Pediatric Oncology Group Experience by KATZENSTEIN, Howard M, KENT, Paul M, LONDON, Wendy B, COHN, Susan L

“…To investigate whether the rate of neurologic recovery or the incidence of long-term sequelae differed for children with neuroblastoma (NB) initially treated…”
Get full text

Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma by Attiyeh, Edward F, London, Wendy B, Mossé, Yael P, Wang, Qun, Winter, Cynthia, Khazi, Deepa, McGrady, Patrick W, Seeger, Robert C, Look, A. Thomas, Shimada, Hiroyuki, Brodeur, Garrett M, Cohn, Susan L, Matthay, Katherine K, Maris, John M

“…More than 900 samples of neuroblastoma were screened for loss of chromosomal material at two loci, 1p36 and 11q23. These abnormalities were associated with…”
Get full text

Malignant retroperitoneal and abdominal germ cell tumors: An intergroup study by Billmire, D., Vinocur, C., Rescorla, F., Colombani, P., Cushing, B., Hawkins, E., Davis, M., London, W.B., Lauer, S., Giller, R.

“…Background/Purpose: This randomized study examined survival (S) and event-free survival (EFS) rates using high-or standard-dose cisplatin-based combination…”
Get full text

Natural history and biology of stage A neuroblastoma : A pediatric oncology group study by ALVARADO, C. S, LONDON, W. B, CASTLEBERRY, R. P, COHN, S. L, LOOK, A. T, BRODEUR, G. M, ALTMILLER, D. H, THORNER, P. S, JOSHI, V. V, ROWE, S. T, NASH, M. B, SMITH, E. I

“…To prospectively analyze the outcome of patients with Stage A neuroblastoma (NB) treated with surgery alone, especially with regard to the prognostic…”
Get full text

Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study by Tebbi, C.K., Mendenhall, N., London, W.B., Williams, J.L., de Alarcon, P.A., Chauvenet, A.R.

“…Purpose The objectives of this study were to evaluate the feasibility of reducing therapy, while maintaining treatment efficacy, in the context of a…”
Get full text

Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators by Wood, Mark A., Simpson, Pippa M., London, Wendy B., Stambler, Bruce S., Herre, John M., Bernstein, Robert C., Ellenbogen, Kenneth A.

“…This study examined the temporal patterns of ventricular tachycardia detections by implantable cardioverter-defibrillators for circadian variability. Previous…”
Get full text

Atypical squamous cells of undetermined significance : A comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up by STASTNY, J. F, REMMERS, R. E, LONDON, W. B, PEDIGO, M. A, CAHILL, L. A, RYAN, M, FRABLE, W. J

“…There is an increasing number of articles regarding the long term follow-up of Papanicolaou (Pap) smears with the diagnosis of atypical squamous cells of…”
Get full text

Malignant mediastinal germ cell tumors: An Intergroup Study by Billmire, Deborah, Vinocur, Charles, Rescorla, Fred, Colombani, Paul, Cushing, Barbara, Hawkins, Edith, London, Wendy B., Giller, Roger, Lauer, Steve

“…This review was conducted to determine clinical characteristics and response to therapy in this rare pediatric neoplasm. An intergroup Pediatric Oncology Group…”
Get full text

MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN by COHN, Susan L, LONDON, Wendy B, DONGHUI HUANG, KATZENSTEIN, Howard M, SALWEN, Helen R, REINHART, Todd, MADAFIGLIO, Janice, MARSHALL, Glenn M, NORRIS, Murray D, HABER, Michelle

“…The clinical significance of MYCN expression in children with neuroblastoma (NB) remains controversial. To determine the prognostic significance of MYCN…”
Get full text